1-8 of 8
Marc Billaud
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 434: Rational molecular assessment and innovative drug selection (RAIDs): exome data from cervical cancer

Free
Suzy Scholl, Maud Kamal, Els Berns, Balzs Balint, Attila Kereszt, Leanne de Koning, Emmanuelle Jeannot, Windy Luscap-rondof, Vonick Sibut, Philippe Hupe, Gemma Kenter, Sanne Samuels, Katja Jordanova, Sandrine Blanchet, Laurence Lafanachere, Marc Billaud, RAIDs consortium
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 434.
https://doi.org/10.1158/1538-7445.AM2016-434
Published: 15 July 2016
View articletitled, Abstract 434: Rational molecular assessment and innovative drug selection (RAIDs): exome data from cervical cancer
Journal Articles

LIM Kinase Inhibitor Pyr1 Reduces the Growth and Metastatic Load of Breast Cancers

Free
Chloé Prunier, Véronique Josserand, Julien Vollaire, Evelyne Beerling, Christos Petropoulos, Olivier Destaing, Christopher Montemagno, Amandine Hurbin, Renaud Prudent, Leanne de Koning, Reuben Kapur, Pascale A. Cohen, Corinne Albiges-Rizo, Jean-Luc Coll, Jacco van Rheenen, Marc Billaud, Laurence Lafanechère
Journal: Cancer Research
Cancer Res (2016) 76 (12): 3541–3552.
https://doi.org/10.1158/0008-5472.CAN-15-1864
Published: 14 June 2016
View articletitled, LIM Kinase Inhibitor Pyr1 Reduces the Growth and Metastatic Load of Breast Cancers
Open the PDF for LIM Kinase Inhibitor Pyr1 Reduces the Growth and Metastatic Load of Breast Cancers in another window
Includes: Multimedia, Supplementary data
Journal Articles

Abstract 5399: Anti-cancer activity of a new LIM-Kinases inhibitor: “LIM-Pyr1”

Free
Chloé Prunier, Julien Vollaire, Véronique Josserand, Anoek Zomer, Amandine Hurbin, Renaud Prudent, Pascale Cohen, Jacco van Rheenen, Jean-Luc Coll, Marc Billaud, Laurence Lafanechère
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 5399.
https://doi.org/10.1158/1538-7445.AM2015-5399
Published: 01 August 2015
View articletitled, Abstract 5399: Anti-cancer activity of a new LIM-Kinases inhibitor: “LIM-Pyr1”
Journal Articles

Genetic and Pharmacologic Inhibition of mTORC1 Promotes EMT by a TGF-β–Independent Mechanism

Free
Ivan Mikaelian, Mouhannad Malek, Rudy Gadet, Jean Viallet, Amandine Garcia, Anaïs Girard-Gagnepain, Cédric Hesling, Germain Gillet, Philippe Gonzalo, Ruth Rimokh, Marc Billaud
Journal: Cancer Research
Cancer Res (2013) 73 (22): 6621–6631.
https://doi.org/10.1158/0008-5472.CAN-13-0560
Published: 14 November 2013
View articletitled, Genetic and Pharmacologic Inhibition of mTORC1 Promotes EMT by a TGF-β–Independent Mechanism
Open the PDF for Genetic and Pharmacologic Inhibition of mTORC1 Promotes EMT by a TGF-β–Independent Mechanism in another window
Includes: Supplementary data
Journal Articles

Is Co-option a Prevailing Mechanism during Cancer Progression?

Free
Marc Billaud, Massimo Santoro
Journal: Cancer Research
Cancer Res (2011) 71 (21): 6572–6575.
https://doi.org/10.1158/0008-5472.CAN-11-2158
Published: 30 October 2011
View articletitled, Is Co-option a Prevailing Mechanism during Cancer Progression?
Open the PDF for Is Co-option a Prevailing Mechanism during Cancer Progression? in another window
Journal Articles

Identification and characterization of human MEX-3, a novel family of RNA-binding proteins that regulate cell proliferation

Free
Karine Buchet-Poyau, Julien Courchet, Jean-Noel Freund, Laurent Duret, Marc Billaud
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1091.
Published: 01 May 2005
View articletitled, Identification and characterization of human MEX-3, a novel family of RNA-binding proteins that regulate cell proliferation
Journal Articles

Tyrosine 1062 of RET-MEN2A Mediates Activation of Akt (Protein Kinase B) and Mitogen-activated Protein Kinase Pathways Leading to PC12 Cell Survival

Free
Gabriella De Vita, Rosa Marina Melillo, Francesca Carlomagno, Roberta Visconti, Maria Domenica Castellone, Alfonso Bellacosa, Marc Billaud, Alfredo Fusco, Philip N. Tsichlis, Massimo Santoro
Journal: Cancer Research
Cancer Res (2000) 60 (14): 3727–3731.
Published: 15 July 2000
View articletitled, Tyrosine 1062 of RET-MEN2A Mediates Activation of Akt (Protein Kinase B) and Mitogen-activated Protein Kinase Pathways Leading to PC12 Cell Survival
Open the PDF for Tyrosine 1062 of RET-MEN2A Mediates Activation of Akt (Protein Kinase B) and Mitogen-activated Protein Kinase Pathways Leading to PC12 Cell Survival in another window
Journal Articles

The Different RET-activating Capability of Mutations of Cysteine 620 or Cysteine 634 Correlates with the Multiple Endocrine Neoplasia Type 2 Disease Phenotype

Free
Francesca Carlomagno, Giuliana Salvatore, Anna Maria Cirafici, Gabriella De Vita, Rosa Marina Melillo, Vittorio de Franciscis, Marc Billaud, Alfredo Fusco, Massimo Santoro
Journal: Cancer Research
Cancer Res (1997) 57 (3): 391–395.
Published: 01 February 1997
View articletitled, The Different RET-activating Capability of Mutations of Cysteine 620 or Cysteine 634 Correlates with the Multiple Endocrine Neoplasia Type 2 Disease Phenotype
Open the PDF for The Different RET-activating Capability of Mutations of Cysteine 620 or Cysteine 634 Correlates with the Multiple Endocrine Neoplasia Type 2 Disease Phenotype in another window